From Medscape Oncology

Medscape Medical News from the:

2014 Genitourinary Cancers Symposium (GUCS)

January 30 - February 01, 2014; San Francisco, California

This coverage is not sanctioned by, nor a part of, the American Society of Clinical Oncology, the American Society for Radiation Oncology, or the Society of Urologic Oncology.

Conference News

GUCS New Agent Misses the Mark in Advanced Prostate Cancer
Medscape Medical News, February 4, 2014
GUCS Epigenetic Test Might Be Prognostic in Prostate Cancer
Medscape Medical News, February 4, 2014
GUCS Cytoreductive Nephrectomy Benefits Some RCC Patients
Medscape Medical News, February 3, 2014
GUCS Long-term Data Show Ra-223 Safe in Advanced Prostate Cancer
Medscape Medical News, January 31, 2014
GUCS Patient Deaths Cause Media Storm in Prostate Cancer Study
Medscape Medical News, January 31, 2014
GUCS Radiotherapy Plus ADT for High-risk Prostate Cancer
Medscape Medical News, January 29, 2014
GUCS One in 5 Clinical Trials in Adult Cancer Not Completed
Medscape Medical News, January 29, 2014
GUCS Kidney Cancer Patients on ASI Antihypertensives Live Longer
Medscape Medical News, January 29, 2014
GUCS Enzalutamide Before Chemo Slows Metastatic Prostate Cancer
Medscape Medical News, January 28, 2014

Medscape Oncology© WebMD, LLC

Previous Coverage